[EN] PYRROLONE OR PYRROLIDINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR 1 D'HORMONE CONCENTRANT LA MÉLANINE DE TYPE PYRROLONE OU PYRROLIDINONE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2014039412A8
公开(公告)日:2015-10-15
Bisarylurea derivatives
申请人:Buchstaller Hans-Peter
公开号:US20070161677A1
公开(公告)日:2007-07-12
The present invention relates to bisarylurea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
US9499482B2
申请人:——
公开号:US9499482B2
公开(公告)日:2016-11-22
[EN] SUBSTITUTED BISARYLUREA DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DERIVES DE BISARYLUREE
申请人:MERCK PATENT GMBH
公开号:WO2005075425A3
公开(公告)日:2006-12-14
PYRROLONE OR PYRROLIDINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS
申请人:Bristol-Myers Squibb Company
公开号:US20150218092A1
公开(公告)日:2015-08-06
The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are melanin concentrating hormone receptor-1 (MCHR1) antagonists which may be used as medicaments.